
样式: 排序: IF: - GO 导出 标记为已读
-
Distinguishing Retrieval Augmented Generation From Prompt Engineering: Implications for Reproducibility in Large Language Model Research and Applications. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-21 Mauro Giuffrè
-
Demystifying Carbohydrate Maldigestion: A Clinical Review. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-18 Brooks D Cash,Daksesh Patel,Kate Scarlata
Carbohydrate intolerance is a poorly understood and potentially overlooked cause of unexplained gastrointestinal symptoms, particularly among patients with disorders of gut-brain interaction. Symptoms related to carbohydrate intolerance arise from bacterial fermentation of unabsorbed carbohydrates leading to increased gases and osmotic load within the gastrointestinal tract. This mechanism is shared
-
Quality of Evidence Backing Recommendations for Eosinophilic Esophagitis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-14 Anil Minocha
-
Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-14 Gian Paolo Caviglia,Arianna Ferro,Roberta D'Ambrosio,Riccardo Perbellini,Pietro Lampertico,Giulia Periti,Luca Valenti,Carlo Ciccioli,Grazia Pennisi,Salvatore Petta,Lucia Brodosi,Maria Letizia Petroni,Francesca Marchignoli,Loris Pironi,Alessandra Sagripanti,Maria Eva Argenziano,Gianluca Svegliati-Baroni,Chiara Rosso,Federica Barutta,Angelo Armandi,Gabriella Gruden,Elisabetta Bugianesi
BACKGROUND AIMS Patients with type 2 diabetes mellitus (T2DM) are at increased risk for metabolic dysfunction-associated steatotic liver disease (MASLD), advanced liver fibrosis, and metabolic dysfunction-associated steatohepatitis (MASH). We evaluated the prevalence and severity of MASLD among patients with T2DM at their first referral to diabetes clinics, and assessed the effectiveness of the 2-tier
-
The Odd Thing About Odds Ratios. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-14 Gabriel V Lupu,Robert S Sandler,Sasha Deutsch-Link
-
Rural-urban disparities in hepatocellular carcinoma deaths are driven by hepatitis C-related HCC. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-11 Andrew M Moon,Gabriel V Lupu,Ellen W Green,Sasha Deutsch-Link,Louise M Henderson,Hanna K Sanoff,Ted K Yanagihara,Nima Kokabi,David M Mauro,A Sidney Barritt
OBJECTIVES Recent data suggest emerging rural-urban disparities in hepatocellular carcinoma (HCC) burden in the US. We aimed to assess (1) trends in rural vs urban HCC-related mortality and (2) differences in underlying chronic liver disease etiologies contributing to HCC-related deaths. METHODS We utilized the National Vital Statistics System to examine crude and age-adjusted HCC death rates overall
-
Adenoma Detection Rates Calculated Using All Exams Are Associated with Lower Risk for Post Colonoscopy Colorectal Cancer: Data From the New Hampshire Colonoscopy Registry. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-11 Joseph C Anderson,Douglas K Rex,Todd A Mackenzie,William Hisey,Christina M Robinson,Lynn F Butterly
INTRODUCTION We used New Hampshire Colonoscopy Registry (NHCR) data to examine the association between post-colonoscopy colorectal cancer (PCCRC) risk and an adenoma detection rate (ADR) which was calculated using exams with all indications, as compared to ADR restricted to only screening exams. METHODS Our cohort study included NHCR patients with an index exam and at least one follow-up event, either
-
Early Stage Crohn's Disease-Associated Small Bowel Adenocarcinoma at Ileal Stenosis Detected by Ballon-Assisted Enteroscopy. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-10 Masashi Ohno,Atsuhi Nishida,Yoshihiro Yokota,Takayuki Imai,Ryoji Kushima,Osamu Inatomi
-
Clinical and HLA associations of fluoroquinolone induced liver injury: results from the Drug-Induced Liver Injury Network. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-10 Jawad Ahmad,Andrew Dellinger,Paola Nicoletti,Huiman X Barnhart,Marwan Ghabril,Robert J Fontana,Victor Navarro,Gina Choi,Paul H Hayashi,Jiezhun Gu,David Kleiner,
BACKGROUND AND AIMS Fluoroquinolones (FQ) have a favorable safety profile, but the risk of drug-induced liver injury (DILI) is well described. The aim of this study was to identify clinical features and HLA genetic variants associated with FQ-DILI in a large national registry. METHODS Analysis of FQ-DILI cases enrolled in DILIN between 2004-2022. HLA class I and II alleles were sequenced by the Illumina
-
Novel Closure of Large Gastric Defect Using a Dual-Channel Endoscope. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-10 Shuangzhu Yang,Jingjing Lian,Aiping Xu,Tao Chen,Meidong Xu
-
THE SAN DIEGO CONSENSUS FOR LARYNGOPHARYNGEAL SYMPTOMS AND LARYNGOPHARYNGEAL REFLUX DISEASE. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-08 Rena Yadlapati,Philip Weissbrod,Erin Walsh,Thomas L Carroll,Walter W Chan,Jackie Gartner-Schmidt,Livia Guadagnoli,Marie Jette,Jennifer C Myers,Ashli O'Rourke,Rami Sweis,Justin Wu,Julie M Barkmeier-Kraemer,Daniel Cates,Chien-Lin Chen,Enrique Coss-Adame,Gregory Dion,David Francis,Mami Kaneko,Jerome R Lechien,Stephanie Misono,Anais Rameau,Sabine Roman,Anne Vertigan,Yinglian Xiao,Frank Zerbib,Madeline
BACKGROUND The term 'laryngopharyngeal reflux' ('LPR') is frequently applied to aerodigestive symptoms despite lack of objective reflux evidence. This initiative aimed to develop a modern care paradigm for LPR supported by otolaryngology and gastroenterology disciplines. METHODS A 28-member international inter-disciplinary working group developed practical statements within the following domains:
-
The Utility of Multitarget Stool DNA Testing in Community-Based Clinical Practice. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-08 Abhinav K Rao,Shivam Kalra,Danny Tran,Angeli Patel,Ibrahim Al-Saadi,Levi C Diggins,Don C Rockey,Brett Van Leer-Greenberg
BACKGROUND Multitarget stool DNA (MT-sDNA) tests (i.e., Cologuard®) serve as screening tests for colorectal cancer (CRC) and are recommended by the USPSTF every 1-3 years. Here, in a primary care setting, our aim was to evaluate the diagnostic performance of MT-sDNA testing and colonoscopy findings following a positive MT-sDNA testing result. METHODS This was retrospective cohort study of electronic
-
CENTORING AND ANCHORING APPROACH TO ENDOSCOPICALLY MANAGE NON-HEALING PEG SITE FISTULA. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-08 Mayank Goyal,Ashwariya Ohri,Preeyati Chopra,Khusbhoo Gala,Navtej S Buttar
-
The Impact of Cannabis Use in Gastroparesis: A Propensity Matched Analysis 41,374 gastroparesis patients. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-08 Yassine Kilani,Daniel Alejandro Gonzalez Mosquera,Priscila Castro Puelo,Mohammad Aldiabat,James K Ruffle,Madi Y Mahmoud,Adam D Farmer
BACKGROUND Cannabinoids are being explored as potential treatments for gastroparesis due to their anti-emetic, gastric motility modulation, appetite stimulation, and analgesic properties coupled with their increasing use due to legalization in many states. While these theoretical benefits are promising, clinical evidence remains limited. This study aimed to evaluate the effects of cannabis use on clinical
-
Is Carbohydrate Intolerance associated with carbohydrate malabsorption in Disorders of Gut-Brain Interaction (DGBI)? Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-08 Hiba Mikhael-Moussa,Charlotte Desprez,André Gillibert,Anne-Marie Leroi,François Mion,Guillaume Gourcerol,Chloé Melchior
INTRODUCTION We aimed to explore the prevalence of carbohydrate (lactose and fructose) intolerance in patients with disorders of gut-brain interaction (DGBI), and to characterize those patients in terms of gastrointestinal and non-gastrointestinal symptoms. METHODS DGBI patients who were referred to the Physiology Unit of our Hospital between May 2022 and December 2023 for lactose (25g) and fructose
-
Rapid Development of Giant Esophageal Pseudo-Diverticulosis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-08 Nishali Shah,Matthew Pelton,Anish Vinit Patel
-
Accurately Predicting Recurrent Primary Sclerosing Cholangitis After Liver Transplantation. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Ming Gao,Xuefeng Ma
-
A case of multiple gastrointestinal ulcers caused by dental floss used for endoscopic submucosal dissection defect closure. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Jiayao Zheng,Shijie Yang,Wanyin Deng
-
PATIENT REPORTED OUTCOME MEASURES IN BENIGN ESOPHAGEAL DISORDERS. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 John E Pandolfino,Ronnie Fass,Walter W Chan,C Prakash Gyawali
Patient-reported outcome (PRO) measures are essential tools for assessing a patient's subjective experience related to disease and health. PROs measure symptom severity and evaluate treatment efficacy across a range of conditions at a particular point in time. While PROs focusing on esophageal symptoms and esophageal hypervigilance exist, disease-specific PROs for commonly encountered benign esophageal
-
A Risk Stratification Tool for Relapse After Intravenous-to-Subcutaneous Switching of Infliximab in Patients with Inflammatory Bowel Diseases. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Yannick Hoffert,Zhigang Wang,Mathurin Fumery,Maria Nachury,Maëva Bazoge,Anthony Buisson,Erwin Dreesen
OBJECTIVES A subcutaneous formulation of infliximab was recently approved for maintenance therapy of inflammatory bowel disease (IBD). However, limited clinical experience, particularly with patients on escalated intravenous infliximab regimens, poses challenges for the transition to subcutaneous therapy. We investigated the pharmacokinetics and pharmacodynamics of subcutaneous infliximab to identify
-
Barrett's Esophagus in Time and Space: A Methylation Panel for Tracking Esophageal Cancer. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Daniel H Jacobson,Rebecca C Fitzgerald
-
Treatment of Clostridioides difficile : The Times They Are Changing. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Paul Feuerstadt,Jessica Allegretti,Sahil Khanna
-
Suggestions to Strengthen a Systematic Review. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Nosaibah Razaqi,Rachana Mehta,Shubham Kumar,Ranjana Sah
-
LONG-TERM SUSTAINED IMPROVEMENT IN UNPLANNED HEALTHCARE UTILIZATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Gil Y Melmed,Brant Oliver,Alice Kennedy,Jason K Hou,Donald Lum,Siddharth Singh,Welmoed K van Deen,Ridhima Oberai,S Alandra Weaver,James Testaverde,Corey A Siegel,
METHODS After the QI initiative, we developed an "urgent care toolkit" for sites to implement. We measured patient- and provider-reported outcomes at clinical visits. RESULTS Improvements in ED utilization and hospitalization were sustained for over 3 years following completion of the initiative. CONCLUSIONS Efforts to sustain improvements after a QI initiative can result in long-term improvement in
-
Efficacy of Polysaccharide Hemostatic Powder on blood oozing among patients with Post-Endoscopic Sphincterotomy Bleeding: A Randomized Controlled Trial. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Hengcun Li,Jiaxuan Zuo,Wenhai Wang,Shanshan Wu,Yu Zhao,Yongqiu Wei,Jiugang Song,Zheng Zhang,Weilong Yao,Junxiong Wang,Chuntao Liu,Hongtao Wei,Zheng Liang,Xiaohan Yang,Kaiqi Yang,Fujing Lv,Yongjun Wang,Peng Li,Shutian Zhang
BACKGROUND AND AIMS Post-endoscopic sphincterotomy (EST) bleeding presents challenges for endoscopists using side-viewing duodenoscopes. Recently, polysaccharide hemostatic powder (PHP) has shown promising results in managing gastrointestinal hemorrhage. Given the established efficacy of endoscopic clips in addressing post-EST bleeding, we aim to evaluate the efficacy of PHP and its non-inferiority
-
Routine Polypectomy Practices Vary Widely Among US Endoscopists and Commonly Deviate from Guidelines: An Analysis of Colonoscopy Registry Data. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Seth D Crockett,Jennifer Holub,Audrey H Calderwood,Rajesh N Keswani
BACKGROUND Best practices for removal of <1 cm colon polyps exist, but adherence to this guidance is uncertain. METHODS Using GI Quality Improvement Consortium (GIQuIC) Registry data, colonoscopies with polyps <1cm were analyzed for polypectomy technique used, and differences in practices according to patient, procedure, and provider characteristics. RESULTS Among 1,830,067 colonoscopies, cold forceps
-
Existential Reflections by Older Adults with Inflammatory Bowel Diseases on Medical and Surgical Treatments. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-07 Alison Rusher,Alexandra Fuss,Elizabeth Araka,Christy Cauley,Sevdenur Cizginer,Christine Ritchie,Ashwin N Ananthakrishnan,Bharati Kochar
OBJECTIVES Current treatment guidelines do not address the unique health risks or life priorities of the aging population with inflammatory bowel diseases (IBD). Patient priority-directed care approaches can facilitate better clinical management for this population. We aimed to explore the experiences of older adults with IBD in relation to medical and surgical treatments by investigating the factors
-
EBACS (ENDOSCOPIC BYPASS OF ABSCESS WITH COVERED STENT). Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-01 Mayank Goyal,Ashwariya Ohri,Preeyati Chopra,Laurens P Janssens,Navtej S Buttar
-
Gastric Adenocarcinoma and Proximal Polyposis Syndrome (GAPPS): An Early Catch! Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-01 Francisco Avila,Ali Mokhtari,Michael H Frist,Romil Saxena
-
Cap Xtender, A Fresh Take on Prolapsing Mucosal Polyp Management. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-01 Mayank Goyal,Preeyati Chopra,Ashwariya Ohri,Laurens P Janssens,Navtej S Buttar
-
Association of Race and Ethnicity With Healthcare Utilization for Inflammatory Bowel Disease in the United States: A Retrospective Cohort Study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-01 Abraham Segura,Colleen Brensinger,Virginia Pate,Shazia M Siddique,Lauren Parlett,Andres Hurtado-Lorenzo,Michael David Kappelman,James D Lewis
INTRODUCTION Advances in medical and surgical therapy have improved the outlook for those affected with Crohn's disease and ulcerative colitis; however, it is unclear whether Americans from marginalized racial and ethnic backgrounds have adequate and equitable access to care for inflammatory bowel disease (IBD). We evaluated the association between race and ethnicity and healthcare utilization in patients
-
Raising the age for starting colonoscopy to 35 years for individuals with path_MSH6 carriers may lead to missed opportunities for detecting advanced neoplasia in a notable percentage of carriers. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-04-01 Maya Aharoni Golan,Lior Katz,Ido Laish,Rakefet Chen-Shtoyerman,Naim Abu-Freha,Revital Kariv,Nathan Gluck,Guy Rosner,Hana Strul,Rachel Gingold-Belfer,Hadar Edelman-Klapper,Tom Konikoff,Alex Vilkin,Itai Maza,Gili Reznick- Levi,Aasem Abu Shataya,Yael Goldberg,Elizabeth E Half,Zohar Levi
INTRODUCTION Recent guidelines for Lynch Syndrome recommend starting a colonoscopy at 30-35 years for path_MSH6 carriers. This study aimed to measure the rate of advanced neoplasia (AN) in these carriers up to age 35. METHODS A multicenter retrospective analysis of endoscopic and pathological data for path_MSH6 carriers who underwent endoscopic surveillance at specialized high-risk clinics. Advanced
-
Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver Disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-31 Phuc Le,Moosa Tatar,Michael B Rothberg,Laura A Wilson,Daniela Allende,Anna Mae Diehl,Rohit Loomba,Naga Chalasani,Brent A Neuschwander-Tetri,Kris Kowdley,Arun J Sanyal,James Tonascia,Srinivasan Dasarathy,
INTRODUCTION The effects of metabolic syndrome (MetS), its individual components, and baseline liver histology, on the rates of progression and regression of nonalcoholic fatty liver disease (NAFLD) were evaluated. METHODS We conducted a post-hoc analysis of a multi-center prospective cohort study using the non-interventional registry of the nonalcoholic steatohepatitis (NASH) Clinical Research Network
-
Liver Cleansing Imposters: An Analysis Of Popular Online Liver Supplements. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-31 Ahmed Telbany,Abhishek Vasantkumar Patel,Pooja Viswanath,Evelyn Inga,Swathi Paleti
BACKGROUND The liver supplement market is rapidly expanding, yet the efficacy and safety of these products remain largely unsubstantiated. This study aimed to analyze the best-selling liver "cleansing" supplements on Amazon®, the leading online retailer in the United States. METHODS We identified the top 20 liver cleanse supplements on Amazon® using specific search criteria. Product composition, marketing
-
A Case of Systemic Sarcoidosis of The Stomach Treated with ESD. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-31 Muyun Liu,Jie Gao,Chang Sun,Ying Chen,Xingang Shi,Wei An
-
Gastric (Foveolar) Dysplasia in Barrett's Esophagus: A Clinical, Molecular and Long-Term Outcome Study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-31 Helen H Wang,Yuho Ono,Thomas G Paulson,William M Grady,Robert D Odze
BACKGROUND AND AIMS The aim of this long-term progression study was to evaluate the clinical and pathologic features of gastric type dysplasia in Barrett's esophagus (BE). METHODS Baseline biopsies from 208 BE patients from the Seattle prospective cohort were evaluated for the type and grade of dysplasia (gastric or intestinal). Twenty-seven patients progressed to cancer and 181 did not over the long
-
Loss of response to off-label swallowed topical corticosteroids in eosinophilic esophagitis can be overcome by a switch to an esophageal-targeted budesonide formulation. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-31 Fritz R Murray,Jean-Benoit Rossel,Ekaterina Safroneeva,Catherine Saner,Bernhard Morell,Andrea Kreienbuehl,Thomas Greuter,Alex Straumann,Luc Biedermann,Alain Schoepfer,Philipp Schreiner
OBJECTIVE Swallowed topical corticosteroids (STC) are effective in treating patients with eosinophilic esophagitis (EoE). However, real-world data about loss of response to STC are limited and whether patients with off-label STC (olSTC) failure may achieve histologic remission after a switch to budesonide orodispersible tablets (BOT), is unknown. METHODS We analyzed prospectively collected data between
-
Proton-Pump Inhibitor Use and Cardiovascular Adverse Event Risk. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-31 Shih-Wei Lai,Kuan-Fu Liao
-
Risk of Colorectal Endoscopic Submucosal Dissection in Older Adults: A Nationwide Study in Japan. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-31 Chikamasa Ichita,Tadahiro Goto,Akiko Sasaki,Kiyohide Fushimi,Sayuri Shimizu
OBJECTIVES To evaluate the risks of colorectal endoscopic submucosal dissection (ESD) in older adult patients, given the increasing number of ESD in an aging population. METHODS We conducted a retrospective cohort study using the Japanese nationwide database from 2012 to 2023. Patients aged ≥60 who underwent colorectal ESD were included. The primary outcome was overall adverse events (AEs), including
-
A Practical Guide to the Use of Guselkumab for Moderate-Severe Ulcerative Colitis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-31 Maia Kayal
-
Overall and Cause-Specific Mortality in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis of Population-Based Studies. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-31 Tarek Sawas,Alex R Jones,Rand Alsawas,Rachna Talluri,Hayley Rogers,Olgert Bardhi,David Spezia-Lindner,Danielle Gerberi,Siddharth Singh,M Hassan Murad,Nicholas J Shaheen,David A Katzka,Sachin Wani
BACKGROUND Current guidelines recommend endoscopic surveillance of Barrett's esophagus (BE), but do not account for competing mortality unrelated to esophageal cancer (EC). We conducted a systematic review and meta-analysis to estimate EC and non-EC mortality risk in BE patients. METHOD We searched multiple databases for studies reporting mortality in BE. We included population-based studies providing
-
Changes in Gastroenterology Service Volumes and Billing Patterns Associated With Declining Medicare Reimbursement. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-27 Jonathan A Busam,Eric D Shah
INTRODUCTION Efforts to control health spending within the United States have led to reductions in physician reimbursement. This study aims to elucidate the effects of such efforts on physician behavior and care access. METHODS For all gastrointestinal procedures, public Medicare data sets were reviewed to extract variables of interest, leveraging a t test to assess significant change over time. RESULTS
-
Training and Performance of an Electrocardiogram-Enabled Machine Learning Model for Detection of Advanced Chronic Liver Disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-27 Puru Rattan,Joseph C Ahn,Beatriz Sordi Chara,Aidan F Mullan,Kan Liu,Zachi I Attia,Paul A Friedman,Alina Allen,Vijay H Shah,Patrick S Kamath,Peter A Noseworthy,Douglas A Simonetto
INTRODUCTION Building on prior results, we hypothesized that an electrocardiogram (ECG)-enabled machine learning (ML) model could be used to detect advanced chronic liver disease (CLD). METHODS A cohort with CLD and 12-lead ECGs was matched with controls from electronic health records. A ML model was trained as a binary classifier. RESULTS There are 12,930 patients with CLD and 64,577 controls in the
-
Evaluating for Celiac Disease in Patients on a Gluten-Free Diet: A Practical Approach. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-27 Rishaan R Sharma,Claire L Jansson-Knodell,Dennis Kumral,Alberto Rubio-Tapia
-
Nature's cystenterostomy: Spontaneous pancreatico-colonic fistulae formation in infected pancreatic walled-off necrosis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-27 Khushboo Gala,Andrew C Storm
-
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in MASLD. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-27 Naim Alkhouri,Terry Cheuk-Fung Yip,Laurent Castera,Marina Takawy,Leon A Adams,Nipun Verma,Juan Pablo Arab,Syed-Mohammed Jafri,Bihui Zhong,Julie Dubourg,Vincent L Chen,Ashwani K Singal,Luis Antonio Díaz,Nicholas Dunn,Rida Nadeem,Vincent Wai-Sun Wong,Manal F Abdelmalek,Zhengyi Wang,Ajay Duseja,Yousef Almahanna,Haya A Omeish,Junzhao Ye,Stephen A Harrison,Jessica Cristiu,Marco Arrese,Sage Robert,Grace
INTRODUCTION The recent FDA-approval of resmetirom for treating metabolic dysfunction-associated steatohepatitis (MASH) in patients necessitates patient selection for significant fibrosis or higher (≥F2). No existing vibration-controlled transient elastography (VCTE) algorithm targets ≥F2. METHODS The ALADDIN study addressed this gap by introducing a machine-learning-based web calculator that estimates
-
Safety and Efficacy of Endoscopic Retrograde Appendicitis Therapy for pediatric patients: A Single-Center Retrospective Study in Chinese Children. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-27 Qiuyue Tu,Saif Ullah,Deliang Li,Lingjian Kong,Dan Liu,Ting Wei,Yajuan Li,Qingfen Zheng,Lixia Zhao,Hongwu Xin,Bingrong Liu
OBJECTIVES Endoscopic retrograde appendicitis therapy (ERAT) is a new and non-invasive endoscopic technique originally developed by Liu in China for the management of acute appendicitis. While its safety and efficacy have been extensively validated in adult populations, evidence regarding its use in pediatric patients remains scarce. The aim of this study was to evaluate the clinical outcomes of ERAT
-
Colonoscopy-related adverse events in the 21st century: an updated systematic review and meta-analysis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-27 Xiu-He Lv,Qing Lu,Zi-Jing Wang,Zhu Wang,Jin-Lin Yang
INTRODUCTION Colonoscopy is one of the most commonly performed endoscopic procedures and is generally considered low-risk. However, when adverse events (AEs) occur, they can present significant challenges in clinical practice. The aim of this study was to estimate the global incidence of colonoscopy-related AEs. METHODS We searched multiple databases for population-based studies reporting the incidence
-
Characteristics of post-polypectomy colorectal cancer events and deaths. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-27 Jiyue Qin,Ashley Earles,Mark Lamm,Hanin Yassin,Joshua Demb,Lin Liu,Samir Gupta
OBJECTIVES Post-polypectomy colorectal cancers (PPCRCs) are diagnosed after a cancer-negative colonoscopy with polypectomy. Analyzing PPCRC characteristics informs prevention and early detection strategies. We investigated interval types and etiologies of PPCRCs using World Endoscopy Organization (WEO) guidelines. METHODS PPCRCs were identified in a retrospective cohort of U.S. Veterans who underwent
-
Ileal Pouch Adenocarcinoma in a Young Patient With Newly Diagnosed Crohn's-Like Disease of the Pouch. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-26 Katie Dunleavy,Katrina Pedersen,Robert Cima,Victor Chedid
-
Pregnancy tTG-IgA seropositivity and maternal and infant health in the Child Health and Development Studies. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-25 Piera M Cirillo,Rajitha D Venkatesh,Jennifer J Iscol,Kajal Sangal,Nickilou Y Krigbaum,Lauren M Zimmermann,Susan M Flaherty,Kartik K Venkatesh,Barbara A Cohn,Alessio Fasano
BACKGROUND We examined associations between pregnancy anti-tissue transglutaminase immunoglobulin A (tTG-IgA) seropositivity, a screening test for celiac disease, and celiac-related conditions in pregnancy and offspring health outcomes. We hypothesized that seropositivity would identify pregnant women and infants at risk of poor health. METHODS The Child Health and Development Studies enrolled pregnant
-
Complications of Ileus and Bowel Obstruction During Pregnancy in Women Who Have Had Surgery for Inflammatory Bowel Disease: A Population-Based Study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-24 Sonia Friedman,Jan Nielsen,Mette Louise Andersen,Bente Mertz Nørgård
INTRODUCTION Women with inflammatory bowel disease (IBD) who have IBD surgery before pregnancy have an increased risk of adverse maternal and fetal outcomes. Very few studies have examined the risks of gastrointestinal complications during pregnancy in this group of women. METHODS Using the Danish national registries, we identified live born children of mothers with ulcerative colitis (UC) or Crohn's
-
Linaclotide for Bowel Preparation: Is "Afterload Reduction" Not Just for Heart Failure Anymore? Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-20 Brian C Jacobson
-
Low Incidence of Varicella in Pediatric Patients With Inflammatory Bowel Disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-18 Freddy Caldera,Mary S Hayney,Francis A Farraye,Monika Fischer,Huiping Xu,Michael D Kappelman
INTRODUCTION Immune-modifying therapies in pediatric inflammatory bowel disease (IBD) increase infection risks, including varicella. METHODS Using Optum's deidentified Clinformatics Data Mart Database, a nationwide US commercial insurance claims database (2007-2022), we conducted a retrospective study of 5,368 patients with IBD aged 21 years or younger matched to a non-IBD cohort. The primary outcome
-
Retraction: Hidden Malabsorptive Syndrome: Sucrase-Isomaltase Deficiency Finally Unveiled in Adulthood S4748. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-17 Haider S Khalil,Kaely Bade
-
Diagnosis of Acute-on-Chronic Liver Failure in Critically Ill Patients With Cirrhosis Using Administrative Data. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-17 Luis Garrido-Trevino,Soongjin Ahn,Elliot B Tapper,Olivia C Walker,Gerald Ogola,Sumeet K Asrani
INTRODUCTION We evaluated the positive predictive value (PPV) of International Classification of Diseases, Tenth Revision ( ICD-10 ) codes used to identify organ failures in critically ill patients with cirrhosis. METHODS A cohort of 315 hospitalized cirrhosis patients was analyzed. PPVs were calculated using chart review as the reference standard. RESULTS Three hundred four patients had an ICD-10
-
Radiopaque Medication Mimicking Esophageal Foreign Body: A Case of Lanthanum Carbonate Misidentification. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-17 Kayleigh C Lewis,Millie D Long,Ellen W Green
-
Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND Studies. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-17 Joana Torres,Julian Panés,Corey A Siegel,Marla C Dubinsky,Parambir S Dulai,Satoshi Tanida,Silvio Danese,Jasmina Kalabic,Jyun-Heng Lai,Nidhi Shukla,Leah Rizzo,Cecile Holweg,Dolly Sharma,Remo Panaccione
INTRODUCTION Patients with ulcerative colitis (UC) experience disruptive symptoms that can impair quality of life (QoL). This study examined the effect of risankizumab (RZB) induction and maintenance treatment on symptom resolution and health-related QoL (HRQoL) outcomes. METHODS For the 12-week induction, patients were randomized to intravenous (IV) RZB 1,200 mg (RZB1200) or placebo (PBO). For the
-
ASSESSING MUCOSAL RECOVERY DURING THE FIRST 15 MONTHS OF ADOPTING A GLUTEN-FREE DIET IN CHILDREN WITH CELIAC DISEASE. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-14 Denis Chang,Madison Wong,Cleo R Davidowitz,Imad Absah,Vahe Badalyan,Mohammad K Chaaban,Lisa Fahey,Daniela M Isaac,Maya Khanna,Marihan Lansing,Edwin Liu,Catherine Raber,Arunjot Singh,Marisa G Stahl,Catharine M Walsh,Jocelyn A Silvester,Maureen M Leonard
OBJECTIVE Determine contemporary rates of early mucosal recovery in children with celiac disease (CeD). METHODS Multicenter retrospective cohort study in Canada and the United States. Children diagnosed with CeD between 2016 and 2021 who underwent a follow-up biopsy within 15 months of diagnosis were included. RESULTS Overall, 96/130 (74%) had mucosal recovery, including 48% (12/25) children who were
-
Can Only Fluid Therapy Be the Answer in Prevention of Postendoscopic Retrograde Pancreatitis? Am. J. Gastroenterol. (IF 8.0) Pub Date : 2025-03-13 Pulkit Jayeshbhai Patel,Devendra Desai,Vikram Dharap,Digvijay Hodgar